Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.

KX-826 is safe and effectively increases hair count in men with hair loss.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Ozenoxacin reduces sebum production, helping manage acne.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

5α-Reductase helps regulate hormone action in toad testes, especially during breeding season.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Rumex japonicus Houtt. may be an effective treatment for atopic dermatitis by reducing inflammation.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Euph E and Euri A from Euphorbia neriifolia help control inflammation and immune response in cells.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Drug repurposing offers a faster, cheaper way to find treatments for rare diseases.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Pranlukast and mirabegron may work as new diabetes drugs.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.